Tuberculosis is an infectious bacterial disease. Although it is treatable with antibiotics, growing anti-tuberculosis drug resistance is posing a major public health problem that threatens progress made in tuberculosis care and control worldwide. Dr. Rajesh Shah, a world-renowned homeopath and secretary of Global Homeopathy Foundation, along with Abhay Chowdhury, famous virologist and director of Haffkine Institute, Mumbai, have developed a new drug from tuberculosis germs for the patients of the dreaded infectious disease. The homeopathic drug developed by the duo is likely to add value to the treatment of tuberculosis, including Multi-Drug Resistant Tuberculosis patients.
Homeopathic medicines called 'Nosodes' are prepared from organisms, including the bacteria and virus responsible for diphtheria, smallpox, measles, and the like; and are in practice long before the vaccines came into existence. Dr. Shah said, "The new method developed by our team is modern and scientific. The new medicine is sourced from current strains of tuberculosis, including the MDR-TB. Medicines prepared from deadly germs can help treat many diseases and the method has been followed for years in developing vaccines. This is the first time that the germ-based drug has been made applicable to TB and it is safe for human consumption. The new nosode prepared from the current strains of tuberculosis organisms is useful for improving the immune system of the patients who may be prone to frequent respiratory infections. It will support the conventional treatment of tuberculosis and can be used along with the allopathic medicines."